返回ChemicalBook首页>CAS数据库列表>115664-39-6

115664-39-6

中文名称 3-羧基地托咪定
CAS 115664-39-6
分子式 C12H12N2O2
分子量 216.24
MOL 文件 115664-39-6.mol
115664-39-6 结构式 115664-39-6 结构式

基本信息

中文别名
地托米定羧酸
3-羧基地托咪定
英文别名
3-Carboxy DetoMidine
Detomidine carboxylic acid
detomidine 3-carboxylic acid
3-(1H-IMidazol-5-ylMethyl)-2-Methylbenzoic Acid
3-(1H-IMIDAZOL-4-YLMETHYL)-2-METHYL-BENZOIC ACID
Benzoic acid, 3-(1H-imidazol-5-ylmethyl)-2-methyl-

物理化学性质

沸点499.6±33.0 °C(Predicted)
密度1.278±0.06 g/cm3(Predicted)
酸度系数(pKa)3.83±0.10(Predicted)

常见问题列表

生物活性
Detomidine carboxylic acid 是 Detomidine 的主要尿代谢产物。Detomidine 是一种合成的 α2-肾上腺素能 (α2-adrenergic) 激动剂,也是一种动物镇痛镇静剂。Detomidine 还具有心脏和呼吸作用以及抗利尿作用。
靶点

α2-adrenergic

体内研究

Horse urine is investigated for metabolites following the oral administration of the large animal analgesic sedative Detomidine to two stallions and intravenous administration of [ 3 H]-Detomidine to a mare. Detomidine carboxylic acid and hydroxydetomidine glucuronic acid conjugate are identified in the urine after the oral doses. About half of the radioactivity of [ 3 H]-Detomidine is excreted in the urine in 12 h after the i.v. dose (80 μg/kg). Most of the excretion occurred between 5 and 12 h in contrast to urine output which is highest 2-5 h after the dosing. The major radioactive metabolite in the urine is Detomidine carboxylic acid. Detomidine carboxylic acid comprises more than two thirds of the total metabolites in all the urine fractions collected.

"115664-39-6" 相关产品信息
33125-97-2